Abstract
Research comparing the effectiveness of different eczema treatments is limited by inconsistency in both outcomes assessed and the measures used. HOME (Harmonising Outcome Measures for Eczema) recommends a core set of outcomes to be reported in all trials of eczema treatments.1 RECAP (RECap for AtoPic eczema) is a seven‐item patient‐reported instrument recommended for capturing eczema control.2 Initial validation work is encouraging, but RECAP’s validity in different populations and the reliability and responsiveness is uncertain.2,3
Original language | English |
---|---|
Number of pages | 2 |
Journal | British Journal of Dermatology |
Early online date | 3 Dec 2020 |
DOIs | |
Publication status | Published - 1 May 2021 |